Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis of 26-hydroxy-22-oxocholestanic frameworks from diosgenin and hecogenin and their in vitro antiproliferative and apoptotic activity on human cervical cancer CaSki cells.
Fernández-Herrera MA, López-Muñoz H, Hernández-Vázquez JM, López-Dávila M, Escobar-Sánchez ML, Sánchez-Sánchez L, Pinto BM, Sandoval-Ramírez J. Fernández-Herrera MA, et al. Bioorg Med Chem. 2010 Apr 1;18(7):2474-84. doi: 10.1016/j.bmc.2010.02.051. Epub 2010 Mar 1. Bioorg Med Chem. 2010. PMID: 20303770
Synthesis of the steroidal glycoside (25R)-3β,16β-diacetoxy-12,22-dioxo-5α-cholestan-26-yl β-D-glucopyranoside and its anti-cancer properties on cervicouterine HeLa, CaSki, and ViBo cells.
Fernández-Herrera MA, Mohan S, López-Muñoz H, Hernández-Vázquez JM, Pérez-Cervantes E, Escobar-Sánchez ML, Sánchez-Sánchez L, Regla I, Pinto BM, Sandoval-Ramírez J. Fernández-Herrera MA, et al. Eur J Med Chem. 2010 Nov;45(11):4827-37. doi: 10.1016/j.ejmech.2010.07.051. Epub 2010 Aug 11. Eur J Med Chem. 2010. PMID: 20801554
Synthesis and biological evaluation of the glycoside (25R)-3β,16β-diacetoxy-22-oxocholest-5-en-26-yl β-d-glucopyranoside: a selective anticancer agent in cervicouterine cell lines.
Fernández-Herrera MA, López-Muñoz H, Hernández-Vázquez JM, López-Dávila M, Mohan S, Escobar-Sánchez ML, Sánchez-Sánchez L, Pinto BM, Sandoval-Ramírez J. Fernández-Herrera MA, et al. Eur J Med Chem. 2011 Sep;46(9):3877-86. doi: 10.1016/j.ejmech.2011.05.058. Epub 2011 May 30. Eur J Med Chem. 2011. PMID: 21703733
Evaluation of the antitumour activity of Rinvanil and Phenylacetylrinvanil on the cervical cancer tumour cell lines HeLa, CaSKi and ViBo.
Sánchez-Sánchez L, Alvarado-Sansininea JJ, Escobar ML, López-Muñoz H, Hernández-Vázquez JM, Monsalvo-Montiel I, Demare P, Regla I, Weiss-Steider B. Sánchez-Sánchez L, et al. Among authors: lopez munoz h. Eur J Pharmacol. 2015 Jul 5;758:129-36. doi: 10.1016/j.ejphar.2015.04.003. Epub 2015 Apr 9. Eur J Pharmacol. 2015. PMID: 25864613
Apoptotic, necrotic, and antiproliferative activity of diosgenin and diosgenin glycosides on cervical cancer cells.
Hernández-Vázquez JMV, López-Muñoz H, Escobar-Sánchez ML, Flores-Guzmán F, Weiss-Steider B, Hilario-Martínez JC, Sandoval-Ramírez J, Fernández-Herrera MA, Sánchez Sánchez L. Hernández-Vázquez JMV, et al. Among authors: lopez munoz h. Eur J Pharmacol. 2020 Mar 15;871:172942. doi: 10.1016/j.ejphar.2020.172942. Epub 2020 Jan 20. Eur J Pharmacol. 2020. PMID: 31972180
Multicomponent synthesis of some new (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-dithiocarbamates and their in vitro anti-proliferative activity against CaSki, MDA-MB-231 and SK-Lu-1 tumour cells as apoptosis inducing agents without necrosis.
Laskar S, Sánchez-Sánchez L, López-Ortiz M, López-Muñoz H, Escobar-Sánchez ML, Sánchez AT, Regla I. Laskar S, et al. Among authors: lopez munoz h. J Enzyme Inhib Med Chem. 2017 Dec;32(1):1129-1135. doi: 10.1080/14756366.2017.1363197. J Enzyme Inhib Med Chem. 2017. PMID: 28868930 Free PMC article.
15 results